Abstract:Approximately 10% of human acute leukemias are involved in chromosomal translocations between the mixed lineage leukemia ( MLL ) gene and over 50 partner genes. MLL -rearranged leukemias occur preferentially in infant and young children and are often associated with poor outcome. MicroRNAs (miRNAs) are an abundant class of small noncoding RNAs which repress gene expression and mRNA stability by base pairing with target mRNAs usually at the 3’-untranslated regions (UTRs). The ten-eleven translocation 1 ( TET1 ), the founding member of the TET family of enzymes (TET1/2/3) that convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), was first identified in MLL -rearranged leukemia. But its definitive role in leukemia was unclear until our recent report published in PNAS (Huang H. et al. 2013). In contrast to the frequent repression and tumor-suppressor roles of the three TET genes observed in various cancers, we showed that TET1 is a direct target of MLL-fusion proteins and significantly up-regulated in MLL -rearranged leukemia, leading to a global increase of 5hmC level. Furthermore, Tet1 plays an indispensable oncogenic role in MLL -rearranged leukemia, through coordination with MLL-fusion proteins in regulating their critical co-targets including Hoxa/Meis1/Pbx3 genes. However, whether TET1 is also post-transcriptionally regulated by miRNAs in hematopoietic cells remains unknown. In the present report, through genome-wide miRNA expression profiling assays, we found that miR-26a and miR-29a were expressed at a significantly lower level in MLL -rearranged AML than in normal controls. The down-regulation of miR-26a and miR-29a is, at least in part, attributed to the transcriptional repression mediated by MLL-fusion proteins and MYC. Interestingly, both miR-26a and miR-29a target TET1 directly at the post-transcriptional level. More importantly, we showed that miR-26a or miR-29a significantly inhibited MLL-fusion-mediated cell transformation in vitro and leukemogenesis in vivo down regulating expression of Tet1 and its downstream target genes. Thus, our data suggest that the transcriptional repression of miR-26a and miR-29a is required for the aberrant overexpression and potent oncogenic role of TET1 in MLL -rearranged leukemia, and that miR-26a and miR-29a play important tumor-suppressor role in leukemogenesis. Taken together, our data reveals a previously unappreciated signaling pathway involving the MLL-fusion/Myc ⊣ miR-26a/miR-29a ⊣ Tet1 circuit in MLL -rearranged leukemia. Our data not only provides novel insight into our understanding of the complex molecular mechanisms underlying the pathogenesis of MLL -rearranged leukemia, but also may lead to the development of novel, more effective therapeutic strategies to treat this type of dismal disease. Disclosures No relevant conflicts of interest to declare.

Microrna-22 Can Regulate Expression of the Long Non-Coding RNA MEG3 in Acute Myeloid Leukemia

Mir-22 Has a Potent Anti-Tumour Role with Therapeutic Potential in Acute Myeloid Leukaemia

Identification of TET1⊣miR-22⊣CREB-MYC Signaling Reveals Potent Tumor-Suppressor Role of Mir-22 in Acute Myeloid Leukemia

Profiling of Micrornas in Aml Cells Following Overexpression or Silencing of the Vegf Gene

MicroRNA Expression Profiles in Acute Myeloid Leukemia with Common Translocations.

Distinct Microrna Expression Profiles In Acute Myeloid Leukemia With Common Translocations

Tet2 Downregulation Promotes Aml Cell Proliferation Via Pim-1 Expression

LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR‐155

Tet2 and Meg3 Promoter Methylation is Associated with Acute Myeloid Leukemia in A Hainan Population

Dysfunction of the WT1- MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways

Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway

Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia

The Knockdown of MAGI2-AS3 Inhibits Drug Resistance in Acute Myeloid Leukemia by Up Regulating Mir-155

Identification of MLL-Fusion/Myc⊣miR-26a/Mir-29a⊣Tet1 Signaling Circuit in MLL-Rearranged Leukemia

Repression Of Mir-495, A Microrna Associated With Favorable Outcome Of Acute Myeloid Leukemia Patients, Is Required For The Mll-Associated Leukemogenesis

MicroRNA: an Important Regulator in Acute Myeloid Leukemia

MiR-335-3p Inhibits Cell Proliferation and Induces Cell Cycle Arrest and Apoptosis in Acute Myeloid Leukemia by Targeting EIF3E

Mir-29A and Mir-142-3p Downregulation and Diagnostic Implication in Human Acute Myeloid Leukemia

Investigating the Microrna-Mrna Regulatory Network in Acute Myeloid Leukemia

Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR‐23a‐3p/SMC1A in acute myeloid leukemia

The Tumor Suppressive Role of Mirna-370 by Targeting FoxM1 in Acute Myeloid Leukemia.